RxDoctor Payments Data

Michael Falk

Pediatrics · Marlton, NJNPI 1316905425

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Daiichi Sankyo Company LTD at 57.0% of the total. Reporting peaked in 2022 at $2,146 and has fallen 93.5% since, to $139 in 2025. Among pediatrics clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,508in general payments, 2019–2025

Across 88 payments — averaging $39.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Company LTD$2K
  • Sanofi-aventis U.S. LLC$209
  • Kaleo, Inc.$206
  • Corium, LLC$172
  • Tris Pharma Inc$147
  • Merck$137
  • plus $637 from 13 others

What the payments were for

  • Royalty or licence$2,00057%
  • Food & beverage$1,50843%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,508 in reported general payments places this provider in the 95th percentile of 1,890 pediatrics providers in New Jersey.

See all pediatrics providers in New Jersey

Other pediatrics in Marlton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →